Complete Filing Data
Oric Pharmaceuticals, Inc. reported Stockholders Equity of $384.36 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Oric Pharmaceuticals, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | -$129.5M | -$127.8M | -$100.7M | -$89.1M | -$78.7M | -$73.7M | -$26.9M | -$21.4M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $407.0K | $121.0K | $1.5M | -$1.2M | -$72.0K | -$31.0K | ||
| Operating Income Loss | -$143.0M | -$142.9M | -$110.8M | -$91.8M | -$78.9M | -$74.2M | -$28.6M | -$22.4M |
| Operating Expenses | $143.0M | $142.9M | $110.8M | $91.8M | $78.9M | $74.2M | $28.6M | $22.4M |
| Nonoperating Income Expense | $13.5M | $15.0M | $10.1M | $2.6M | $156.0K | $483.0K | $1.7M | $1.0M |
| General And Administrative Expense | $33.2M | $28.8M | $25.6M | $25.1M | $22.0M | $13.4M | $5.7M | $3.3M |
| Research And Development Expense Excluding Acquired In Process Cost | $109.8M | $114.1M | $85.2M | $61.7M | $56.9M | $35.9M | $22.8M | $19.0M |
| Comprehensive Income Net Of Tax | -$129.1M | -$127.7M | -$99.1M | -$90.3M | -$78.8M | -$73.7M | -$26.9M | -$21.4M |
| Interest Income Expense Nonoperating Net | $2.6M | $141.0K | $306.0K | $1.4M | $775.0K | |||
| Other Nonoperating Income | $0.00 | $15.0K | $177.0K | $289.0K | $233.0K | |||
| Research And Development In Process | $5.0M | $0.00 | $24.8M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$32.6M | -$36.4M | -$30.0M | -$34.6M | -$32.0M | -$25.0M | -$25.5M | -$22.9M | -$23.9M | -$24.8M | -$20.3M | -$23.2M | -$18.4M | -$21.0M | -$16.5M | -$25.5M | -$11.0M | -$8.9M | -$6.5M | -$6.0M | -$6.0M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $428.0K | -$22.0K | -$170.0K | $978.0K | -$94.0K | -$420.0K | $198.0K | -$68.0K | $792.0K | -$516.0K | -$429.0K | -$699.0K | -$5.0K | -$14.0K | $48.0K | -$29.0K | |||||
| Operating Income Loss | -$36.7M | -$39.1M | -$32.7M | -$38.3M | -$36.0M | -$29.0M | -$28.7M | -$25.0M | -$25.7M | -$25.7M | -$20.7M | -$23.3M | -$18.5M | -$21.1M | -$16.6M | -$25.6M | -$11.1M | -$9.2M | -$7.1M | -$6.4M | -$6.3M |
| Operating Expenses | $36.7M | $39.1M | $32.7M | $38.3M | $36.0M | $29.0M | $28.7M | $25.0M | $25.7M | $25.7M | $20.7M | $23.3M | $18.5M | $21.1M | $16.6M | $25.6M | $11.1M | $9.2M | $7.1M | $6.4M | $6.3M |
| Nonoperating Income Expense | $4.1M | $2.7M | $2.7M | $3.8M | $4.1M | $4.0M | $3.2M | $2.0M | $1.7M | $865.0K | $409.0K | $99.0K | $30.0K | $48.0K | $44.0K | $54.0K | $99.0K | $307.0K | $548.0K | $390.0K | $331.0K |
| General And Administrative Expense | $7.9M | $8.5M | $8.1M | $7.1M | $7.1M | $7.0M | $6.3M | $6.2M | $6.2M | $6.0M | $6.9M | $6.4M | $5.6M | $5.5M | $4.9M | $3.8M | $3.4M | $1.9M | $1.5M | $1.3M | $1.1M |
| Research And Development Expense Excluding Acquired In Process Cost | $28.8M | $30.5M | $24.6M | $31.2M | $28.9M | $22.0M | $22.4M | $18.8M | $19.5M | $14.7M | $13.8M | $16.8M | $12.9M | $15.5M | $11.7M | $8.8M | $7.7M | $7.3M | $5.6M | ||
| Comprehensive Income Net Of Tax | -$32.2M | -$36.4M | -$30.2M | -$33.6M | -$32.1M | -$25.4M | -$25.3M | -$23.0M | -$23.2M | -$25.3M | -$20.7M | -$23.9M | -$18.4M | -$21.0M | -$16.5M | -$25.6M | -$11.0M | -$8.9M | -$6.5M | ||
| Interest Income Expense Nonoperating Net | $1.7M | $865.0K | $409.0K | $99.0K | $30.0K | $33.0K | $44.0K | $10.0K | $25.0K | $241.0K | $476.0K | $317.0K | $261.0K | ||||||||
| Other Nonoperating Income | $15.0K | $44.0K | $74.0K | $66.0K | $72.0K | $73.0K | $70.0K | ||||||||||||||
| Research And Development In Process | $5.0M | $0.00 | $13.0M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $384.4M | $243.1M | $224.1M | $222.4M | $273.0M | $289.8M | -$90.1M | -$64.4M | -$43.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $46.2M | $59.9M | $23.9M | $67.3M | $226.5M | $78.4M | $89.2M | $42.6M | $25.8M |
| Cash And Cash Equivalents At Carrying Value | $45.7M | $59.4M | $23.4M | $66.8M | $226.0M | $78.4M | $89.2M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$13.7M | $36.0M | -$43.4M | -$159.2M | $148.0M | -$10.7M | $46.5M | $16.8M | |
| Retained Earnings Accumulated Deficit | -$692.2M | -$562.8M | -$434.9M | -$334.2M | -$245.1M | -$166.4M | -$92.7M | ||
| Property Plant And Equipment Net | $2.4M | $2.9M | $2.9M | $3.3M | $2.4M | $2.0M | $2.2M | ||
| Prepaid Expense And Other Assets Current | $7.0M | $6.3M | $4.4M | $4.2M | $3.5M | $3.1M | $840.0K | ||
| Liabilities Current | $20.4M | $24.8M | $20.5M | $15.4M | $15.2M | $9.0M | $5.4M | ||
| Liabilities And Stockholders Equity | $408.9M | $274.1M | $252.0M | $247.2M | $298.6M | $299.0M | $94.1M | ||
| Liabilities | $24.5M | $31.0M | $27.9M | $24.8M | $25.7M | $9.2M | $6.1M | ||
| Assets Current | $288.5M | $262.3M | $212.6M | $210.5M | $240.5M | $296.7M | $90.0M | ||
| Assets | $408.9M | $274.1M | $252.0M | $247.2M | $298.6M | $299.0M | $94.1M | ||
| Additional Paid In Capital Common Stock | $1.08B | $805.5M | $658.8M | $557.9M | $518.2M | $456.2M | $2.6M | ||
| Accrued Liabilities Current | $16.6M | $23.3M | $19.5M | $14.1M | $13.3M | $8.2M | $5.2M | ||
| Accounts Payable Current | $3.8M | $1.5M | $944.0K | $1.3M | $1.9M | $757.0K | $152.0K | ||
| Other Assets Noncurrent | $7.2M | $9.0M | $9.7M | $11.5M | $12.3M | $319.0K | $1.9M | ||
| Common Stock Value | $11.0K | $7.0K | $6.0K | $5.0K | $4.0K | $4.0K | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $786.0K | $379.0K | $258.0K | -$1.3M | -$103.0K | -$31.0K | |||
| Accretion Amortization Of Discounts And Premiums Investments | $2.3M | $8.1M | $6.2M | $1.0M | -$1.3M | -$299.0K | $0.00 | ||
| Other Liabilities Noncurrent | $4.1M | $6.2M | $7.5M | $9.4M | $10.5M | $219.0K | |||
| Available For Sale Securities Debt Securities Current | $235.8M | $196.6M | $184.8M | $139.4M | $11.0M | $215.2M | |||
| Available For Sale Securities Debt Securities Noncurrent | $110.8M | $0.00 | $26.9M | $22.0M | $43.4M | $0.00 | |||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Gain Loss On Disposition Of Assets1 | $0.00 | -$22.0K | -$40.0K | -$2.0K | -$8.0K | -$15.0K | |||
| Restricted Cash And Cash Equivalents | |||||||||
| Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 | $436.0K | $43.0K | |||||||
| Exercise Of Common Stock Options And Vesting Of Early Exercised Common Stock Options Value | |||||||||
| Deferred Rent Credit Noncurrent | $219.0K | $765.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $406.9M | $324.0M | $219.7M | $274.0M | $302.4M | $328.6M | $247.4M | $268.8M | $202.8M | $214.8M | $236.9M | $253.1M | $291.5M | $258.3M | $276.1M | $184.4M | $195.2M | -$98.4M | -$82.2M | -$75.9M | -$70.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $50.2M | $76.4M | $49.8M | $44.7M | $50.3M | $56.9M | $26.7M | $104.2M | $59.5M | $29.5M | $49.5M | $113.1M | $241.6M | $170.1M | $104.2M | $62.0M | $196.6M | $79.4M | $96.4M | $96.3M | $52.3M |
| Cash And Cash Equivalents At Carrying Value | $49.7M | $75.9M | $49.3M | $44.2M | $49.8M | $56.4M | $26.2M | $103.7M | $59.0M | $29.1M | $49.1M | $112.6M | $241.1M | $170.1M | $104.2M | $62.0M | $196.6M | $79.4M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$10.1M | $33.0M | -$7.9M | $113.4M | $25.8M | -$9.7M | $9.6M | ||||||||||||||
| Retained Earnings Accumulated Deficit | -$661.7M | -$629.2M | -$592.8M | -$526.5M | -$491.9M | -$459.9M | -$406.6M | -$381.1M | -$358.2M | -$313.4M | -$288.6M | -$268.3M | -$222.3M | -$203.9M | -$182.9M | -$138.1M | -$112.6M | -$101.6M | |||
| Property Plant And Equipment Net | $2.6M | $2.8M | $3.0M | $3.1M | $2.9M | $2.8M | $3.1M | $3.3M | $3.1M | $3.0M | $3.0M | $2.5M | $1.8M | $1.8M | $2.0M | $1.9M | $2.0M | $2.1M | |||
| Prepaid Expense And Other Assets Current | $8.5M | $8.6M | $7.7M | $7.1M | $8.2M | $7.3M | $4.9M | $4.2M | $3.5M | $5.0M | $6.5M | $4.5M | $3.3M | $3.9M | $2.0M | $2.4M | $2.6M | $788.0K | |||
| Liabilities Current | $20.2M | $18.1M | $17.6M | $21.2M | $19.5M | $15.2M | $18.9M | $14.5M | $14.9M | $13.3M | $12.5M | $11.8M | $11.9M | $9.9M | $7.7M | $6.9M | $5.8M | $4.8M | |||
| Liabilities And Stockholders Equity | $431.2M | $346.9M | $242.9M | $302.1M | $328.9M | $350.8M | $274.3M | $291.8M | $226.6M | $238.0M | $259.7M | $275.1M | $314.2M | $268.2M | $284.0M | $191.7M | $201.5M | $85.1M | |||
| Liabilities | $24.3M | $22.9M | $23.1M | $28.1M | $26.5M | $22.1M | $26.9M | $23.0M | $23.8M | $23.2M | $22.8M | $22.0M | $22.6M | $9.9M | $7.9M | $7.3M | $6.3M | $5.4M | |||
| Assets Current | $295.6M | $291.1M | $211.4M | $279.4M | $294.6M | $324.1M | $232.2M | $268.4M | $193.2M | $198.7M | $233.5M | $239.1M | $292.8M | $265.0M | $280.1M | $189.1M | $199.2M | $80.2M | |||
| Assets | $431.2M | $346.9M | $242.9M | $302.1M | $328.9M | $350.8M | $274.3M | $291.8M | $226.6M | $238.0M | $259.7M | $275.1M | $314.2M | $268.2M | $284.0M | $191.7M | $201.5M | $85.1M | |||
| Additional Paid In Capital Common Stock | $1.07B | $952.9M | $812.3M | $799.7M | $794.6M | $788.7M | $654.4M | $650.5M | $561.5M | $529.9M | $526.7M | $522.1M | $513.9M | $462.2M | $459.0M | $322.5M | $307.8M | $3.1M | |||
| Accrued Liabilities Current | $17.3M | $14.9M | $12.5M | $17.0M | $17.2M | $12.2M | $15.2M | $11.3M | $12.9M | $11.8M | $10.4M | $10.9M | $11.5M | $9.1M | $7.1M | $5.3M | $4.4M | $4.0M | |||
| Accounts Payable Current | $2.9M | $3.1M | $5.2M | $4.2M | $2.3M | $3.0M | $3.7M | $3.2M | $1.9M | $1.5M | $2.1M | $888.0K | $419.0K | $838.0K | $606.0K | $1.6M | $1.4M | $770.0K | |||
| Other Assets Noncurrent | $7.1M | $7.8M | $8.4M | $9.6M | $9.3M | $9.2M | $10.2M | $10.6M | $11.1M | $12.0M | $12.4M | $11.9M | $12.6M | $1.4M | $1.9M | $711.0K | $319.0K | $317.0K | |||
| Common Stock Value | $11.0K | $9.0K | $7.0K | $7.0K | $7.0K | $7.0K | $6.0K | $6.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $615.0K | $187.0K | $209.0K | $722.0K | -$256.0K | -$162.0K | -$369.0K | -$567.0K | -$499.0K | -$1.7M | -$1.2M | -$802.0K | -$2.0K | $3.0K | $17.0K | -$29.0K | |||||
| Accretion Amortization Of Discounts And Premiums Investments | $882.0K | $2.2M | $861.0K | -$42.0K | -$441.0K | ||||||||||||||||
| Other Liabilities Noncurrent | $4.1M | $4.8M | $5.5M | $6.8M | $7.0M | $6.9M | $8.0M | $8.5M | $9.0M | $9.9M | $10.3M | $10.2M | $10.7M | $209.0K | |||||||
| Available For Sale Securities Debt Securities Current | $237.5M | $206.6M | $154.4M | $228.1M | $236.6M | $260.4M | $201.1M | $160.5M | $130.6M | $164.6M | $178.0M | $122.0M | $48.4M | ||||||||
| Available For Sale Securities Debt Securities Noncurrent | $125.9M | $45.2M | $20.0M | $10.0M | $22.1M | $14.7M | $28.9M | $9.6M | $19.3M | $24.3M | $10.8M | $21.6M | $7.0M | ||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||
| Gain Loss On Disposition Of Assets1 | |||||||||||||||||||||
| Restricted Cash And Cash Equivalents | $491.0K | $491.0K | $491.0K | $491.0K | $491.0K | $491.0K | $491.0K | $491.0K | $468.0K | $468.0K | $468.0K | $468.0K | $468.0K | $0.00 | |||||||
| Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 | $78.0K | $101.0K | $135.0K | ||||||||||||||||||
| Exercise Of Common Stock Options And Vesting Of Early Exercised Common Stock Options Value | $53.0K | $39.0K | $12.0K | $14.0K | $59.0K | $21.0K | |||||||||||||||
| Deferred Rent Credit Noncurrent | $359.0K | $500.0K | $635.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $25.0M | $20.2M | $15.2M | $14.5M | $12.9M | $5.3M | $1.1M | $469.0K |
| Proceeds From Stock Options Exercised | $2.0M | $631.0K | $59.0K | $79.0K | $986.0K | $443.0K | $131.0K | $79.0K |
| Payments To Acquire Property Plant And Equipment | $712.0K | $1.2M | $849.0K | $2.1M | $939.0K | $667.0K | $768.0K | $525.0K |
| Net Cash Provided By Used In Operating Activities | -$111.0M | -$112.7M | -$85.7M | -$75.1M | -$59.5M | -$45.3M | -$23.5M | -$20.7M |
| Net Cash Provided By Used In Investing Activities | -$148.0M | $22.1M | -$43.4M | -$109.2M | $158.4M | -$216.0M | -$768.0K | -$508.0K |
| Net Cash Provided By Used In Financing Activities | $245.3M | $126.5M | $85.7M | $25.2M | $49.1M | $250.5M | $70.8M | $38.0M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.8M | -$143.0K | -$1.6M | -$1.0M | -$1.1M | $2.3M | -$234.0K | $297.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$7.2M | $1.8M | $3.3M | -$1.5M | $2.9M | $4.3M | $986.0K | -$410.0K |
| Payments To Acquire Investments | $399.8M | $251.9M | $239.2M | $238.1M | $69.6M | $225.5M | ||
| Proceeds From Sale And Maturity Of Marketable Securities | $252.5M | $275.2M | $196.7M | $131.0M | $229.0M | $10.0M | ||
| Proceeds From Issuance Of Common Stock | $244.4M | $125.0M | $85.0M | $25.0M | $50.0M | $271.3M | ||
| Payments Of Stock Issuance Costs Associated With Financings | $168.0K | $227.0K | $399.0K | $1.9M | $21.2M | $99.0K | ||
| Proceeds From Issuance Of Common Stock Under The Employee Stock Purchase Plan | $1.3M | $1.1M | $826.0K | $545.0K | $0.00 | |||
| Proceeds From Issuance Of Preferred Stock And Preference Stock | $0.00 | $0.00 | $70.8M | $37.9M | ||||
| Proceeds From Sale Of Notes Receivable | $0.00 | $193.0K | $17.0K | |||||
| Payments Of Stock Issuance Costs | $2.4M | $168.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $6.6M | $5.0M | $3.6M | $3.9M | $2.7M | $527.0K | $191.0K |
| Proceeds From Stock Options Exercised | $253.0K | $198.0K | $0.00 | $16.0K | $16.0K | $12.0K | $21.0K |
| Payments To Acquire Property Plant And Equipment | $387.0K | $218.0K | $310.0K | $723.0K | $182.0K | $4.0K | $100.0K |
| Net Cash Provided By Used In Operating Activities | -$32.5M | -$30.2M | -$20.6M | -$22.7M | -$14.9M | -$8.3M | -$5.5M |
| Net Cash Provided By Used In Investing Activities | $22.5M | -$61.9M | $12.8M | -$90.7M | $40.6M | $189.0K | -$100.0K |
| Net Cash Provided By Used In Financing Activities | $11.0K | $125.0M | $0.00 | $16.0K | $16.0K | -$1.6M | $15.3M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $575.0K | $2.4M | -$1.1M | $536.0K | -$1.4M | -$53.0K | $289.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$7.9M | -$5.8M | -$792.0K | -$3.3M | -$3.2M | -$237.0K | $340.0K |
| Payments To Acquire Investments | $64.7M | $114.4M | $43.4M | $99.9M | $25.2M | ||
| Proceeds From Sale And Maturity Of Marketable Securities | $87.5M | $52.7M | $56.5M | $10.0M | $66.0M | ||
| Proceeds From Issuance Of Common Stock | $0.00 | $125.0M | $0.00 | ||||
| Payments Of Stock Issuance Costs Associated With Financings | $168.0K | $0.00 | |||||
| Proceeds From Issuance Of Common Stock Under The Employee Stock Purchase Plan | |||||||
| Proceeds From Issuance Of Preferred Stock And Preference Stock | $15.3M | ||||||
| Proceeds From Sale Of Notes Receivable | $193.0K | ||||||
| Payments Of Stock Issuance Costs | $0.00 | $168.0K | $15.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.47 | -$1.83 | -$1.96 | -$2.25 | -$2.07 | -$3.36 | -$14.15 | -$12.32 |
| Common Stock Shares Outstanding | 98.5M | 71.0M | 54.9M | 45.1M | 39.4M | 36.7M | 2.0M | |
| Common Stock Shares Issued | 98.5M | 71.0M | 54.9M | 45.1M | 39.4M | 36.7M | 2.0M | |
| Common Stock Shares Authorized | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 26.8M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 87.8M | 69.7M | 51.5M | 39.7M | 38.0M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 87.8M | 69.7M | 51.5M | 39.7M | 38.0M | |||
| Earnings Per Share Basic | $-1.47 | $-1.83 | $-1.96 | $-2.25 | $-2.07 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 0.00 | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 38.0M | 21.9M | 1.9M | 1.7M | ||||
| Temporary Equity Shares Outstanding | 0.00 | 19.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.33 | -$0.47 | -$0.42 | -$0.49 | -$0.45 | -$0.37 | -$0.44 | -$0.50 | -$0.53 | -$0.63 | -$0.51 | -$0.59 | -$0.47 | -$0.57 | -$0.45 | -$0.84 | -$0.51 | -$4.46 | -$3.36 | -$3.19 | -$3.32 |
| Common Stock Shares Outstanding | 97.3M | 86.2M | 71.1M | 70.6M | 67.7M | 67.4M | 54.5M | 54.5M | 45.1M | 39.6M | 39.6M | 39.4M | 39.3M | 36.7M | 36.7M | 30.5M | 29.9M | 2.0M | |||
| Common Stock Shares Issued | 97.3M | 86.2M | 71.1M | 70.6M | 67.7M | 67.4M | 54.5M | 54.5M | 45.1M | 39.6M | 39.6M | 39.4M | 39.3M | 36.7M | 36.7M | 30.5M | 29.9M | 2.0M | |||
| Common Stock Shares Authorized | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 26.8M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Shares Outstanding Basic | 99.0M | 78.1M | 71.0M | 70.5M | 70.3M | 67.3M | 57.4M | 45.7M | 45.1M | 39.6M | 39.5M | 39.4M | 39.0M | 36.7M | |||||||
| Weighted Average Number Of Diluted Shares Outstanding | 99.0M | 78.1M | 71.0M | 70.5M | 70.3M | 67.3M | 57.4M | 45.7M | 45.1M | 39.6M | 39.5M | 39.4M | 39.0M | 36.7M | |||||||
| Earnings Per Share Basic | $-0.33 | $-0.47 | $-0.42 | $-0.49 | $-0.45 | $-0.37 | $-0.44 | $-0.50 | $-0.53 | $-0.63 | $-0.51 | $-0.59 | $-0.47 | $-0.57 | |||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | ||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 39.4M | 39.0M | 36.7M | 36.7M | 30.3M | 21.6M | 2.0M | 1.9M | 1.9M | 1.8M | |||||||||||
| Temporary Equity Shares Outstanding | 19.3M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $25.0M | $20.2M | $15.2M | $14.5M | $12.9M | $5.3M | $1.1M | $469.0K |
| Stock Issued During Period Value Stock Options Exercised | $2.0M | $631.0K | $59.0K | $79.0K | $986.0K | $443.0K | $131.0K | $79.0K |
| Depreciation | $1.2M | $1.1M | $1.0M | $966.0K | $897.0K | $970.0K | $1.0M | $903.0K |
| Stock Issued During Period Value New Issues | $242.0M | $124.8M | $84.8M | $25.0M | $50.0M | |||
| Stock Issued During Period Shares Stock Options Exercised | 390.1K | 152.2K | 13.5K | 48.1K | 160.3K | 117.1K | ||
| Stock Issued During Period Value Employee Stock Purchase Plan | $1.3M | $1.1M | $826.0K | $545.0K | ||||
| Stock Issued During Period Shares New Issues | 14.1M | 9.3M | ||||||
| Interest Income Other | ||||||||
| Conversion Of Stock Amount Converted1 | $0.00 | $178.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $5.6M | $6.6M | $6.6M | $5.1M | $5.0M | $5.0M | $3.9M | $3.8M | $3.6M | $3.3M | $4.1M | $3.9M | $3.4M | $3.2M | $2.7M | $1.7M | $1.4M | $527.0K | $271.0K | $190.0K | $191.0K |
| Stock Issued During Period Value Stock Options Exercised | $749.0K | $34.0K | $253.0K | $126.0K | $293.0K | $198.0K | $31.0K | $1.0K | $61.0K | $16.0K | $99.0K | $58.0K | $16.0K | $53.0K | $39.0K | $12.0K | $21.0K | ||||
| Depreciation | $302.0K | $261.0K | $253.0K | $251.0K | $229.0K | $250.0K | $242.0K | ||||||||||||||
| Stock Issued During Period Value New Issues | $108.7M | $133.3M | $124.8M | $84.8M | $50.0M | ||||||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 53.0K | 51.5K | 16.00 | 8.5K | 18.4K | 13.4K | |||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $757.0K | $523.0K | $400.0K | $354.0K | |||||||||||||||||
| Stock Issued During Period Shares New Issues | |||||||||||||||||||||
| Interest Income Other | $0.00 | $0.00 | $0.00 | $15.0K | |||||||||||||||||
| Conversion Of Stock Amount Converted1 |
Most recent annual filing with the SEC: February 23, 2026
Data sourced from SEC EDGAR public filings as of August 9, 2026.